Medcamp S.A.

Equities

MDP

PLTCHPR00019

Real Estate Development & Operations

End-of-day quote Warsaw S.E. Other stock markets 03:30:00 09/05/2024 am IST			5-day change	1st Jan Change
0.6 ^PLN	0.00%		+7.14%	+2.74%

12/02	Medcamp S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
12/02	Medcamp S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Medcamp S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022

May 14, 2022 at 01:08 am IST

Medcamp S.A. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported net loss was PLN 0.417929 million compared to net income of PLN 5.29 million a year ago.

Latest news about Medcamp S.A.

Medcamp S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	12/02	CI
Medcamp S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	12/02	CI
Medcamp S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Medcamp S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	11/23/11	CI
Medcamp S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	12/23/12	CI
Medcamp S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	10/23/10	CI
Medcamp S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	10/23/10	CI
Medcamp S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
Medcamp S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	12/22/12	CI
Medcamp S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	14/22/14	CI
Medcamp S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021	14/22/14	CI
Medcamp S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	14/22/14	CI
Medcamp S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	12/21/12	CI
Medcamp S.A. cancelled the acquisition of an unknown majority stake in NewLab Systems sp.z o.o. from majority shareholder.	26/21/26	CI
INC Private Equity Alternatywna Spolka Inwestycyjna cancelled the acquisition of 6.5% stake in Medcamp S.A. from INC S.A..	25/21/25	CI
JR HOLDING Alternatywna Spolka Inwestycyjna S.A. cancelled the acquisition of 10.02% stake in Medcamp S.A. from Moonrock Enterprise S.A.	12/21/12	CI
Medcamp S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	12/21/12	CI
JR Holding Asi S.A. acquired additional 19.1% stake in Medcamp S.A..	03/20/03	CI
Medcamp S.A. agreed to acquire an unknown majority stake in NewLab Systems sp.z o.o. from majority shareholder.	26/20/26	CI
INC Private Equity Alternatywna Spolka Inwestycyjna agreed to acquire 6.5% stake in Medcamp S.A. from INC S.A. for PLN 3.9 million.	25/20/25	CI
JR HOLDING Alternatywna Spolka Inwestycyjna S.A. agreed to acquire 10.02% stake in Medcamp S.A. from Moonrock Enterprise S.A. for PLN 0.26 million.	13/20/13	CI
Medcamp S.A. agreed additional 34% stake in genXone S.A from Torox Eko FIZAN fund managed by AgioFunds Towarzystwo Funduszy Inwestycyjnych S.A.	13/20/13	CI
An unknown buyer acquired an unknown minority stake in Komorniki Z1 Sp. z o.o. from Medcamp S.A. for PLN 1 million.	28/19/28	CI
Widok 800 Sp. Z O.O. acquired 55% stake in Projekt Karolewska Sp. Z O.O. from Medcamp S.A. for PLN 1.6 million.	25/18/25	CI
Fr Finance Spolka Akcyjna acquired 6.94% stake in Medcamp S.A. from Blumerang Investors S.A. and Moonrock Enterprise S.A.	30/18/30	CI

Chart Medcamp S.A.

Duration

Period

More charts

Company Profile

Medcamp SA, formerly T2 Investment SA, is a Poland-based company engaged in the real estate operations. The Company is involved in the acquisition, management, redevelopment and upgrade, as well as rental and sale of commercial properties, including office areas and warehouses. In addition, the Company is involved in long-term investments in construction and real estate entities. It conducts rental and redevelopment projects, such as Poznan, Jasielska; Poznan, Komorniki; Poznan, Jasielska, Inkubator; Szamotuly, Dworcowa; among others. The Company aims to build a research and development center in Poznan, specializing in such areas as personalized medicine, genetics, genomics and bioinformatics, supported by artificial intelligence, The Company operates through subsidiaries, including T2 Inkubator Sp z o o, T2 Szamotuly Sp z o o, Polskie Centrum Badan i Rozwoju Sp z o o, among others. The majority shareholder of the Company is Moonrock Enterprise SA.

Sector

Real Estate Development & Operations

More about the company

Income Statement Evolution

More financial data

Sector Other Real Estate Development & Operations

	1st Jan change	Capi.
MEDCAMP S.A.	+2.74%	3.93M
CHINA RESOURCES LAND LIMITED	+14.64%	29.29B
MITSUI FUDOSAN CO., LTD.	+36.86%	28.36B
SUN HUNG KAI PROPERTIES LIMITED	-8.82%	25.5B
DLF LIMITED	+13.69%	24.47B
MITSUBISHI ESTATE CO., LTD.	+50.95%	23.83B
CHINA OVERSEAS LAND & INVESTMENT LTD.	+11.92%	21.57B
EMAAR PROPERTIES	+1.39%	19.32B
SUMITOMO REALTY & DEVELOPMENT CO., LTD.	+31.19%	16.73B
POLY DEVELOPMENTS AND HOLDINGS GROUP CO., LTD.	-1.82%	15.96B

Other Real Estate Development & Operations